ClinicalTrials.govpublic full text
A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants
healthy, ad, alzheimer disease, as-s603, mild cognitive impairment, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842967
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.